evalu
indirect
immunofluoresc
assay
base
virusinfect
cell
detect
antisever
acut
respiratori
syndromeassoci
coronaviru
sarscov
immunoglobulin
ig
g
antibodi
confirm
sar
case
demonstr
seroconvers
fourfold
rise
igg
antibodi
titer
control
posit
sensit
specif
assay
immunofluoresc
assay
ascertain
statu
sarscov
infect
conduct
studi
teach
hospit
chines
univers
hong
kong
princ
wale
hospit
major
outbreak
sar
occur
patient
admit
clinic
featur
suggest
sar
investig
sarscov
infect
combin
method
includ
direct
detect
viral
rna
reversetranscript
polymeras
chain
reaction
rtpcr
use
primer
viru
isol
use
african
green
monkey
kidney
vero
cell
serolog
rtpcrposit
result
confirm
repeat
test
origin
sampl
isol
posit
result
confirm
detect
sarscov
rna
cultur
supernat
rtpcr
purpos
studi
analysi
patient
defin
true
sar
case
follow
two
condit
fulfil
criteria
probabl
case
sar
one
specimen
posit
sarscov
rtpcr
isol
march
may
identifi
patient
fulfil
definit
true
sar
case
sixteen
die
convalescentphas
blood
sampl
could
collect
receiv
convalescentphas
plasma
therapi
case
exclud
result
true
sar
case
analyz
three
pediatr
patient
age
year
eightysix
adult
year
age
mean
sd
femal
remain
elderli
patient
year
mean
sd
femal
pneumonia
develop
patient
five
requir
intens
care
eventu
recov
four
die
infect
patient
admit
princ
wale
hospit
respiratori
tract
infect
febril
ill
use
nonsar
control
convalescentphas
serum
sampl
collect
patient
viral
atyp
pneumonia
serolog
screen
retriev
studi
control
group
consist
patient
pediatr
patient
month
year
age
mean
sd
girl
adult
age
year
mean
sd
femal
control
year
age
mean
sd
femal
overal
control
group
confirm
infect
respiratori
virus
atyp
pathogen
addit
hospit
patient
healthi
group
includ
nonsar
control
group
compris
medic
student
year
age
mean
sd
femal
blood
sampl
submit
prevaricellazost
viru
vaccin
screen
retriev
studi
antisarscov
igg
antibodi
detect
indirect
immunofluoresc
techniqu
vero
cell
monolay
confluenc
inocul
sarscov
coronaviru
stock
use
third
passag
isol
grown
sar
patient
full
genom
sequenc
isol
publish
genbank
access
infect
cell
harvest
cytopath
effect
observ
cell
monolay
laboratori
condit
event
occur
consist
hour
viru
inocul
infect
cell
mix
noninfect
vero
cell
ratio
wash
three
time
phosphatebuff
salin
pb
cell
spot
onto
teflonco
glass
microscop
slide
slide
allow
airdri
fix
minut
prechil
aceton
store
use
serum
sampl
heatinactiv
minut
dilut
pb
aliquot
dilut
serum
sampl
place
coat
well
incub
minut
moist
chamber
wash
three
time
pb
fluorescein
isothiocyanateconjug
rabbit
antihuman
igg
antibodi
dako
denmark
ad
dilut
incub
minut
test
run
posit
control
serum
known
titer
test
twofold
serial
dilut
guard
sensit
result
crosscheck
two
experienc
technician
diagnost
approach
perform
screen
test
dilut
serum
sampl
collect
day
onset
ill
upon
special
circumst
test
might
perform
earlier
sampl
screen
result
posit
followup
test
twofold
serial
dilut
start
perform
togeth
correspond
acutephas
serum
sampl
hand
screen
result
neg
show
nonspecif
fluoresc
signal
followup
sampl
collect
repeat
test
addit
titer
obtain
second
sampl
third
sampl
collect
repeat
test
seroconvers
fourfold
rise
antibodi
titer
regard
serolog
evid
recent
sarscov
infect
serolog
data
true
sar
case
use
analysi
base
result
obtain
routin
test
run
outbreak
laboratoryperform
screen
test
conduct
everi
altern
day
followup
titrat
test
occur
next
day
sampl
includ
test
run
base
clinician
request
contain
variabl
proport
case
turn
nonsar
technician
know
result
sar
investig
test
sampl
nonsar
control
test
run
contain
test
sampl
mix
known
posit
control
test
blind
fashion
total
serum
sampl
true
sar
case
test
antisar
igg
antibodi
four
sampl
show
fluoresc
signal
cell
fix
slide
sinc
mix
infect
cell
equal
amount
noninfect
cell
expect
observ
genuin
posit
signal
approxim
cell
fix
slide
therefor
four
sampl
regard
nonspecif
followup
sampl
obtain
patient
test
posit
overal
case
show
seroconvers
show
fourfold
rise
antibodi
titer
posit
rate
antibodi
titer
respect
time
specimen
collect
shown
tabl
detect
earliest
seroconvers
day
onset
fever
antibodyposit
rate
sampl
collect
day
onset
fever
respect
sampl
obtain
nonsar
control
group
show
fluoresc
signal
cell
fix
slide
sampl
regard
nonspecif
remain
sampl
neg
antisar
igg
antibodi
serolog
diagnosi
remain
indispens
mean
confirm
viral
infect
statu
antibodi
assay
base
virusinfect
cell
whole
viral
lysat
might
produc
crossreact
infect
close
relat
virus
common
coldassoci
coronaviru
infect
highli
preval
specif
whole
virusbas
assay
diagnosi
sarscov
infect
concern
result
indic
infect
cellbas
indirect
immunofluoresc
test
antisar
igg
antibodi
provid
sensit
specif
howev
immunofluoresc
test
rel
labor
intens
experienc
technician
requir
examin
result
particular
differenti
nonspecif
signal
posit
result
properti
make
test
ideal
largescal
studi
nevertheless
high
sensit
specif
make
test
applic
ascertain
infect
statu
serv
refer
assess
perform
highthroughput
secondgener
assay
enzym
immunoassay
immunofluoresc
test
also
use
confirmatori
assay
sampl
reactiv
screen
assay
develop
feasibl
assay
high
throughput
perform
pursu
evalu
role
class
antisarscov
antibodi
diagnosi
sarscov
infect
need
